Johnson & Johnson (BMV:JNJ)

Market Cap	8.98T
Revenue (ttm)	1.69T
Net Income (ttm)	461.06B
Shares Out	n/a
EPS (ttm)	189.94
PE Ratio	19.47
Forward PE	18.75
Dividend	98.40 (2.63%)
Ex-Dividend Date	Nov 25, 2025

Volume	15
Average Volume	206
Open	3,714.55
Previous Close	3,723.86
Day's Range	3,714.55 - 3,737.80
52-Week Range	2,836.00 - 3,870.45
Beta	0.35
RSI	53.27
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD